Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Survival and organ involvement in patients with limited cutaneous systemic sclerosis and anti-topoisomerase-I antibodies: determined by skin subtype or auto-antibody subtype? A long-term follow-up study.
Kranenburg P, van den Hombergh WM, Knaapen-Hans HK, van den Hoogen FH, Fransen J, Vonk MC. Kranenburg P, et al. Among authors: van den hombergh wm. Rheumatology (Oxford). 2016 Nov;55(11):2001-2008. doi: 10.1093/rheumatology/kew298. Epub 2016 Aug 12. Rheumatology (Oxford). 2016. PMID: 27520796
Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function.
van den Hombergh WMT, Simons SO, Teesselink E, Knaapen-Hans HKA, van den Hoogen FHJ, Fransen J, Vonk MC. van den Hombergh WMT, et al. Clin Rheumatol. 2018 Oct;37(10):2715-2722. doi: 10.1007/s10067-018-4171-6. Epub 2018 Jul 10. Clin Rheumatol. 2018. PMID: 29987427 Free PMC article.
Hit hard and early: analysing the effects of high-dose methylprednisolone on nailfold capillary changes and biomarkers in very early systemic sclerosis: study protocol for a 12-week randomised controlled trial.
van den Hombergh WMT, Kersten BE, Knaapen-Hans HKA, Thurlings RM, van der Kraan PM, van den Hoogen FHJ, Fransen J, Vonk MC. van den Hombergh WMT, et al. Trials. 2018 Aug 22;19(1):449. doi: 10.1186/s13063-018-2798-x. Trials. 2018. PMID: 30134971 Free PMC article. Clinical Trial.
Efficacy of methylprednisolone in very early systemic sclerosis: results of the "Hit hard and early'' randomized controlled trial.
Kersten BE, Lemmers JMJ, Vanhaecke A, Velauthapillai A, van den Hombergh WMT, van den Hoogen FHJ, van den Ende CHM, Smith V, Vonk MC. Kersten BE, et al. Among authors: van den hombergh wmt. Rheumatology (Oxford). 2024 Mar 29:keae156. doi: 10.1093/rheumatology/keae156. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38552324